未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Inhibition of VEGF signaling prevents exhaustion and enhances anti-leukemia efficacy of CAR-T cells via Wnt/β-catenin pathway 抑制VEGF信号通路可预防CAR-T细胞的耗竭，并通过Wnt/β-catenin通路增强其抗白血病效果。 Wu, Suwan; Wei, Yiyi; Qiu, Yingqi; Ai, Kexin; Chen, Mu; Wang, Hao; Zhang, Honghao; Cen, Qingyan; Liao, Peiyun; Ding, Xiangyang; Xie, Xiaoling; Li, Yuhua 分享 收藏
分享 收藏
DUBA sustains the stability of NOD2 and RIPK2 to enhance innate immune responses DUBA维持NOD2和RIPK2的稳定性以增强先天免疫应答 Zhou, Bincheng; Yin, Maojin; Su, Xian; Sheng, Suhui; Du, Xue; Shen, Jiangyun; Chen, Kangmin; Wang, Deqi; Zhu, Zhenhu; Xu, Yanqi; Li, Zhongding; Li, Jianmin; Li, Yuhua; Ruan, Jing; Wang, Xu 分享 收藏
Overexpression of Pin1 regulated by TOP2A, which subsequently stabilizes Pyk2 to promote bortezomib resistance in multiple myeloma Zhang, Honghao; Chen, Jianyu; Meng, Yabo; Cen, Qingyan; Wang, Hao; Ding, Xiangyang; Ai, Kexin; Yang, Yulu; Gao, Yang; Qiu, Yingqi; Hu, Yuxing; Li, Meifang; He, Yanjie; Li, Yuhua 分享 收藏
Recommendations for the timing, dosage, and usage of corticosteroids during cytokine release syndrome (CRS) caused by chimeric antigen receptor (CAR)-T cell therapy for hematologic malignancies Tu, Sanfang; Luo, Xiu; Mei, Heng; Hu, Yongxian; Liu, Yang; Li, Ping; Zou, Dehui; Niu, Ting; Xu, Kailin; Zhang, Xi; Qiu, Lugui; Gao, Lei; Gao, Guangxun; Zhang, Li; Feng, Yimei; Wang, Ying; Zhao, Mingfeng; Mi, Jianqing; Hou, Ming; Yang, Jianmin; Huang, He; Wang, Jianxiang; Hu, Yu; Zhao, Weili; Wu, Depei; Ma, Jun; Li, Yuhua; Qian, Wenbin; Huang, Xiaojun; Han, Weidong; Liang, Aibin 分享 收藏
Dendritic cell vaccines extend CAR T-cell persistence and improve the efficacy of CD19 CAR T-cell therapy in refractory or relapsed adult B-ALL patients Tu, Sanfang; Zhou, Lijuan; Huang, Rui; Zhou, Xuan; Yang, Jilong; He, Yanjie; Hu, Yuxing; Zhang, Honghao; Xie, Xiaoling; Li, Yuhua 分享 收藏
Prognosis and immunotherapy efficacy in dMMR&MSS colorectal cancer patients and an MSI status predicting model Fu, Xinhui; Huang, Jinglin; Zhu, Junling; Fan, Xinjuan; Wang, Chao; Deng, Weihao; Tan, Xiaoli; Chen, Zhiting; Cai, Yacheng; Lin, Hanjie; Wang, Guannan; Zhang, Ning; Zhu, Yongmin; Chen, Ji; Zhan, Huanmiao; Huang, Shuhui; Fang, Yongzhen; Li, Yuhua; Huang, Yan 分享 收藏
Targeting PARP14 with lomitapide suppresses drug resistance through the activation of DRP1-induced mitophagy in multiple myeloma Zhang, Honghao; Wang, Hao; Hu, Yuxing; Gao, Yang; Chen, Jianyu; Meng, Yabo; Qiu, Yingqi; Hu, Rong; Liao, Peiyun; Li, Meifang; He, Yanjie; Liang, Zhao; Xie, Xiaoling; Li, Yuhua 分享 收藏
A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China Wang, Ying; Wu, Depei; Zhang, Xiang; Li, Yuhua; He, Yanjie; Liu, Qifa; Xuan, Li; Li, Zhenyu; Qi, Kunming; Sun, Yuqian; Wang, Shunqing; Mo, Wenjian; Gao, Lei; Hua, Ye; Wang, Yu; Zhang, Ying 分享 收藏
CLPs-miR-103a-2-5p inhibits proliferation and promotes cell apoptosis in AML cells by targeting LILRB3 and Nrf2/HO-1 axis, regulating CD8+T cell response Cen, Qingyan; Chen, Jianyu; Guo, Jiaxin; Chen, Mu; Wang, Hao; Wu, Suwan; Zhang, Honghao; Xie, Xiaoling; Li, Yuhua 分享 收藏
Venetoclax plus a hypomethylating agent versus cytarabine, aclarubicin, and granulocyte colony-stimulating factor chemotherapy as a first-line therapy for newly diagnosed acute myeloid leukemia: A propensity score-matched analysis Venetoclax联合低甲基化药物与阿糖胞苷，阿克拉霉素和粒细胞集落刺激因子化疗作为新诊断的急性髓系白血病的一线治疗: 倾向评分匹配分析 Huang, Rui; He, Honghua; Xu, Xiaoli; Lin, Xiaonan; Dong, Ying; Wang, Xiaotao; Jiang, Fang; Huang, Pengcheng; Mo, Shuyi; Huang, Zhenqian; Wang, Yaya; Tao, Hongfang; Zheng, Yaling; Wu, Ming; Yang, Chuting; Zheng, Ziyu; Zhao, Ying; Zhang, Yuming; Li, Yuhua 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
.png){kind=icon}
分享.png){kind=icon}
收藏
.png)
CANCER